Reaction
Prostatic Operation reporting signals
As of the last recalculation, Prostatic Operation appears in 1,176 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is RELUGOLIX (PRR 45.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Relugolix | 58 | 45.7 | 45.8 |
| Ibrutinib | 114 | 27.6 | 27.6 |
| Finasteride | 53 | 16.2 | 16.2 |
| Dolutegravir Sodium | 7 | 13.8 | 13.8 |
| Rasagiline Mesylate | 7 | 11.2 | 11.2 |
| Icosapent Ethyl | 5 | 10.4 | 10.4 |
| Abiraterone | 7 | 9.1 | 9.2 |
| Vibegron | 4 | 8.9 | 8.9 |
| Rotigotine | 7 | 8.6 | 8.6 |
| Fesoterodine Fumarate | 5 | 8.2 | 8.2 |
| Risankizumab-Rzaa | 36 | 8.0 | 8.0 |
| Abiraterone Acetate | 14 | 6.1 | 6.1 |
| Apalutamide | 3 | 4.5 | 4.5 |
| Droxidopa | 4 | 3.3 | 3.3 |
| Pimavanserin Tartrate | 8 | 2.6 | 2.6 |